IL6 and neoplasm: Furthermore, increased FIS-1 expression in cachectic skeletal muscle from tumor-bearing mice is dependent on IL-6; tumor-bearing mice treated with an IL-6 receptor antibody demonstrated an attenuation of muscle STAT3 and FIS-1 expression [15].